Or will it? Over the past few years, Mylan has had executives give themselves some serious raises. The FDA is looking into this, but will continue their work once all the executives get back from the Bahamas.
However, whatever the case, it's still far too much for most families, considering an EpiPen expires faster than milk. (Well, 6 months). Mylan, embarrassed, released a generic version for $300 instead. It's kind of like when the bully asks to either give you a wedgie or you give them your lunch money. You're going to give them your lunch money, because it just sucks less. Opponents are still arguing that the price is still outrageous.
Maybe we're not all Epinefriends, after all.








